Overview

Hair Repigmentation During Cerebrolysin Therapy

Status:
Completed
Trial end date:
2016-12-23
Target enrollment:
Participant gender:
Summary
Open-label histological study of scalp biopsies from patients undergoing treatment with Cerebrolysin as therapy for cerebrovascular disease. The aim is to assess by histological techniques the causes of follicular repigmentation that occurs during the Cerebrolysin treatment.
Phase:
N/A
Details
Lead Sponsor:
Universidad Autonoma de Nuevo Leon
Collaborator:
Hospital Universitario Dr. Jose E. Gonzalez
Treatments:
Cerebrolysin